Pet Scanners Market Size, Share, Growth, and Industry Analysis, By Type (PET Scanners (Only Including PET),PET-CT Scanners), By Application (Hospitals/ Clinics,Pharmaceutical Companies,Diagnostic Center,Other), Regional Insights and Forecast to 2035

Pet Scanners Market Overview

The global Pet Scanners Market is forecast to expand from USD 1114.5 million in 2026 to USD 1153.62 million in 2027, and is expected to reach USD 1519.74 million by 2035, growing at a CAGR of 3.51% over the forecast period.

The global Pet Scanners Market is experiencing substantial expansion driven by rising diagnostic imaging use, with more than 62% of all oncology PET imaging procedures in 2023 employing advanced PET-CT systems and approximately 10.2% year-on-year growth in scan volumes reported in 2023.

In the United States the Pet Scanners Market is characterised by the highest per-capita installation rate: in 2023 U.S. PET scan volumes rose to an average of 1,495 scans per system, representing roughly 67% of all fixed-site PET sites reporting growth expectation next year.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 67% of PET imaging sites globally reported increased procedure volume expectations over the next twelve months.
• Major Market Restraint: 45% of imaging centres cite high cost of PET scanner equipment and maintenance as primary adoption barrier.
• Emerging Trends: 58% of new PET scanner installs between 2022-2024 were full-ring or hybrid PET-CT models with time-of-flight (TOF) enhancements.
• Regional Leadership: North America holds roughly 41.7% share of the global Pet Scanners Market in 2025.
• Competitive Landscape: Top five manufacturers captured more than 52% share of global PET scanner shipments in 2023.
• Market Segmentation: PET-CT modality constituted about 81.9% of total PET scanner installations in 2023.
• Recent Development: 66% of new product launches in 2023 focused on AI-enabled image reconstruction for PET/CT scanners.

Pet Scanners Market Latest Trends

In recent years the Pet Scanners Market Trends reveal notable shifts such as increased uptake of hybrid PET-CT scanners in oncology centres, where about 47% of all PET procedures in 2023 were oncology-related. Many imaging departments now report average scan times dropping from 45 minutes to 30 minutes due to time-of-flight detector upgrades and streamlined workflows. Adoption of digital PET detectors is gaining pace; approximately 34.5% of new installations in 2024 incorporated lutetium oxyorthosilicate (LSO) crystals, enhancing sensitivity and reducing false negatives.

Pet Scanners Market Dynamics

The PET Scanners Market Dynamics section explores the fundamental forces shaping growth, competitive behavior, and investment direction in the global PET imaging ecosystem. As of 2024, there are more than 6,500 operational PET and PET-CT scanners worldwide, with hybrid PET-CT systems accounting for 81.9% of installed units.

DRIVER

"Rising prevalence of oncology, cardiology and neurology diagnostic volumes."

The main driver of the Pet Scanners Market is the increasing burden of cancer, cardiovascular disease and neurological disorders globally, which requires advanced imaging capabilities. In 2023 total PET scan volume increased 10.2% year-on-year and fixed-site scan average rose from 1,401 in 2022 to 1,495 in 2023.

RESTRAINT

"High capital expenditure and limited reimbursement in emerging markets."

A significant restraint for the Pet Scanners Market is the high capital cost of acquiring PET or PET-CT systems and the challenge of consistent reimbursement policies. In many developing nations, less than 35% of scans are reimbursed by health systems and imaging centres often face cost recovery periods exceeding 5 years.

OPPORTUNITY

"Growth in outpatient imaging centres, mobile PET units and expansion into emerging markets."

An important opportunity in the Pet Scanners Market exists in outpatient imaging centres and mobile PET units, where demand is increasing for regional service lines. In the U.S., mobile PET adoption grew by roughly 12% of new contract wins in 2023.

CHALLENGE

"Technological complexity, maintenance costs and skilled workforce shortage."

A key challenge for the Pet Scanners Market is managing technological complexity and ensuring operational efficiency. PET/CT systems require specialized maintenance, costly parts and trained nuclear medicine technologists and physicians. Roughly 62% of PET sites reported that recruitment of staff with PET experience is a constraint.

Pet Scanners Market Segmentation

The Pet Scanners Market Segmentation Analysis divides the market by type (PET scanners only including PET, PET-CT scanners) and by application (Hospitals/Clinics, Pharmaceutical Companies, Diagnostic Centres, Other). According to Pet Scanners Market Size and Share data, PET-CT scanners held approximately 81.9% of all new installations in 2023, while standalone PET scanners comprised the remaining share.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

PET Scanners (Only Including PET): The standalone PET scanner segment retains a niche role in the Pet Scanners Market Research Report, representing around 18.1% of installations in 2023. These systems are typically used in dedicated research centres, academic institutions and specialised neuro-imaging labs where cost constraints or space limitations preclude hybrid models.

The PET Scanners segment in the Global PET Scanners Market is projected to reach USD 412.3 million by 2034, capturing 28.1% of the total market share and expanding at a CAGR of 3.48% through 2034.

Top 5 Major Dominant Countries in the PET Scanners Segment

• United States: The United States market is projected to reach USD 108.6 million by 2034, accounting for 26.3% of global share and expanding at a CAGR of 3.52%. Market growth is sustained by advanced diagnostic infrastructure, a large number of tertiary hospitals, and extensive use of PET imaging in oncology and neuroscience.
• Germany: Germany is forecasted to achieve USD 61.5 million by 2034, holding 14.9% share and growing at a CAGR of 3.47%, supported by advanced healthcare infrastructure and expanding oncology diagnostic networks.
• China: China’s market is estimated to reach USD 74.2 million by 2034, capturing 18.0% share and expanding at a CAGR of 3.53%. The rapid establishment of nuclear medicine departments across 500+ tertiary hospitals and national policies supporting local PET manufacturing have made China one of the fastest-growing markets globally.
• Japan: Japan is expected to record USD 54.7 million by 2034, representing 13.3% share with a CAGR of 3.46%. High adoption in neurology and oncology, over 1,450 scans per unit annually, and continuous government support for digital imaging modernization drive sustained growth.
• India: India’s market is projected to reach USD 42.8 million by 2034, maintaining 10.4% share and expanding at a CAGR of 3.51%. Growth is propelled by the expansion of diagnostic networks, increased cancer screening demand, and the development of domestic radiotracer manufacturing capabilities.

PET-CT Scanners: The PET-CT scanner segment dominates the Pet Scanners Market Size and Share landscape, representing about 81.9% of all installs in 2023. These hybrid systems combine metabolic imaging with structural CT data, enhancing diagnostic confidence for oncology, cardiology and neurology applications.

The PET-CT Scanners segment is projected to reach USD 1,055.9 million by 2034, representing approximately 71.9% of the global PET Scanners Market share and growing steadily at a compound annual growth rate (CAGR) of 3.53%.

Top 5 Major Dominant Countries in the PET-CT Scanners Segment

• United States: The United States market for PET-CT Scanners is projected to reach USD 310.5 million by 2034, accounting for 29.4% of global share and expanding at a CAGR of 3.55%. The country leads due to over 2,800 operational PET-CT systems, rapid AI-based software integration, and rising oncology imaging demand across major medical centers and outpatient diagnostic chains.
• Germany: Germany’s market is expected to achieve USD 178.9 million by 2034, holding 16.9% share and expanding at a CAGR of 3.49%, supported by strong healthcare infrastructure and robust investments in hybrid diagnostic technologies. The nation’s advanced radiology network and extensive hospital-based PET programs continue to reinforce its leadership within Europe’s molecular imaging segment.
• China: China is forecasted to reach USD 165.6 million by 2034, capturing 15.7% of total share and growing at a CAGR of 3.54%. The country’s increasing adoption of hybrid imaging systems across public hospitals, coupled with government-led healthcare expansion, drives consistent PET-CT installations in oncology and cardiology diagnostic segments.
• Japan: Japan’s PET-CT Scanners Market is estimated to reach USD 124.3 million by 2034, representing 11.8% share with a CAGR of 3.50%. Growth is supported by ongoing modernization of diagnostic infrastructure, early cancer detection initiatives, and strong collaborations between hospitals and academic imaging research institutions.
• France: France is projected to attain USD 95.8 million by 2034, accounting for 9.1% of global market share and expanding at a CAGR of 3.47%. The steady growth is driven by national investments in molecular imaging, increasing clinical trial activity, and upgrades of legacy systems with high-resolution PET-CT scanners across hospital networks.

BY APPLICATION

Hospitals/Clinics: The hospitals and clinics application segment in the Pet Scanners Market Analysis accounted for over 52.2% of total installations in 2023, supported by more than 60% of sites having at least one physician reading PET scans and an uptake rate of 67% of sites projecting increased volumes. Hospital imaging departments increased average PET scans per system from 1,401 in 2022 to 1,495 in 2023, reflecting higher demand.

The Hospitals and Clinics segment is projected to reach USD 623.7 million by 2034, representing 42.5% of the global PET Scanners Market share and expanding at a CAGR of 3.52%. This segment continues to dominate due to the growing number of hospital-based diagnostic imaging departments adopting PET and PET-CT systems for oncology, cardiology, and neurology applications.

Top 5 Major Dominant Countries in the Hospitals / Clinics Application

• United States: The U.S. market is expected to reach USD 165.3 million by 2034, accounting for 26.5% share and growing at a CAGR of 3.54%. Strong adoption in multidisciplinary hospitals and major oncology networks, supported by over 2,500 installed PET-CT systems, underscores the country’s leadership in hybrid imaging utilization and advanced care integration.
• Germany: Germany is projected to attain USD 94.2 million by 2034, representing 15.1% of global share with a CAGR of 3.50%. Expanding PET infrastructure in tertiary hospitals and collaborations between radiology and oncology departments continue to drive steady growth across major German healthcare institutions.
• China: China’s hospital segment is forecasted to reach USD 83.7 million by 2034, capturing 13.4% share and expanding at a CAGR of 3.55%. The country’s ongoing healthcare modernization initiatives and integration of hybrid imaging units across public hospitals have strengthened its PET adoption rate significantly.
• Japan: Japan is estimated to record USD 68.1 million by 2034, holding 10.9% of market share with a CAGR of 3.49%. The country’s healthcare focus on early diagnosis and technology-driven imaging has increased PET deployment in hospitals and medical research centers nationwide.
• France: France is expected to reach USD 54.4 million by 2034, capturing 8.7% share and expanding at a CAGR of 3.47%. National health funding initiatives and cancer-screening programs continue to accelerate the replacement of traditional imaging systems with hybrid PET-CT solutions across the public healthcare network.

Pharmaceutical Companies: The pharmaceutical companies application segment is significant in the Pet Scanners Market Research Report for drug development and radiopharmaceutical R&D; in 2023 approximately 9% of PET scans used tracers such as Pylarify and Ga-68 PSMA-11, reflecting research and therapeutic monitoring use.

The Pharmaceutical Companies segment is projected to reach USD 253.9 million by 2034, accounting for 17.3% market share and expanding at a CAGR of 3.50%. Growth is primarily driven by the expanding use of PET imaging in clinical research, radiopharmaceutical development, and pharmacokinetic studies during drug trials.

Top 5 Major Dominant Countries in the Pharmaceutical Companies Application

• United States: The U.S. market is projected to reach USD 69.5 million by 2034, representing 27.4% share and growing at a CAGR of 3.53%. High investment in radiotracer development, clinical trial imaging, and partnerships between OEMs and biotech firms drive the country’s dominance.
• Germany: Germany is forecasted to reach USD 43.7 million by 2034, holding 17.2% share and expanding at a CAGR of 3.49%. Increased pharmaceutical imaging research in oncology and neuroscience accelerates PET system procurement in major European R&D facilities.
• China: China’s segment is expected to attain USD 47.1 million by 2034, accounting for 18.6% of market share with a CAGR of 3.52%. State-backed pharmaceutical expansion and growth in tracer manufacturing facilities are major contributors to PET adoption.
• Japan: Japan is estimated to reach USD 37.4 million by 2034, capturing 14.7% share and expanding at a CAGR of 3.48%. Growing focus on nuclear medicine research and molecular imaging integration within pharma laboratories continues to fuel market development.
• India: India’s market is forecasted to reach USD 31.6 million by 2034, representing 12.4% share and expanding at a CAGR of 3.51%. Increasing contract research activity and clinical trial imaging demand support strong momentum in pharmaceutical PET system installations.

Diagnostic Centre: The diagnostic centres application segment in the Pet Scanners Industry Analysis is accelerating, with approximately 38% of new PET/CT units in 2023 installed outside large hospital networks, reflecting outpatient and multispecialty imaging hub expansion. These centres benefit from mobile PET solutions and leasing models, capturing growing share of regional imaging demand.

The Diagnostic Centers segment is projected to reach USD 412.5 million by 2034, representing 28.1% of total market share and expanding at a CAGR of 3.53%.

Top 5 Major Dominant Countries in the Diagnostic Centers Application

• United States: The U.S. market is forecasted to reach USD 102.8 million by 2034, capturing 24.9% share with a CAGR of 3.55%. Expansion of private diagnostic centers and mobile PET units has contributed significantly to volume growth across outpatient imaging networks.
• Germany: Germany’s market is expected to reach USD 67.2 million by 2034, holding 16.3% share and expanding at a CAGR of 3.50%. Private diagnostic groups and healthcare startups continue to modernize their imaging infrastructure with next-generation hybrid PET scanners.
• China: China is projected to record USD 76.5 million by 2034, representing 18.5% share and growing at a CAGR of 3.54%. Public-private partnerships and diagnostic franchise development in tier-2 cities drive market expansion and imaging accessibility.
• Japan: Japan’s diagnostic center market is estimated to reach USD 58.1 million by 2034, accounting for 14.1% share and expanding at a CAGR of 3.49%. Growth is influenced by strong outpatient service networks and rising health screening demand.
• India: India is projected to achieve USD 46.3 million by 2034, holding 11.2% market share and growing at a CAGR of 3.51%. Increased adoption of hybrid PET systems and localized tracer supply has made diagnostics more affordable and widely available.

Other: The “Other” application category in the Pet Scanners Market Insights includes academic research institutions, veterinary hospitals and mobile imaging units. In 2023 about 4% of new PET/CT installs were in mobile units, and approximately 3% in veterinary or non-human applications.

The Other Applications segment, encompassing academic institutions, veterinary centers, and mobile imaging facilities, is projected to reach USD 178.1 million by 2034, accounting for 12.1% of global share and expanding at a CAGR of 3.49%. The segment benefits from expanding research collaborations and increasing demand for mobile diagnostic solutions in underserved regions.

Top 5 Major Dominant Countries in the Other Applications Segment

• United States: The U.S. market is projected to reach USD 45.6 million by 2034, capturing 25.6% share with a CAGR of 3.51%, driven by expanding academic imaging partnerships and mobile PET initiatives for regional healthcare services.
• Germany: Germany’s market is estimated to reach USD 32.1 million by 2034, representing 18.0% share and growing at a CAGR of 3.48%, supported by university-based research laboratories and increased government-funded medical imaging studies.
• China: China is forecasted to reach USD 39.2 million by 2034, accounting for 22.0% share and expanding at a CAGR of 3.53%, driven by medical university collaborations and mobile imaging infrastructure development in remote provinces.
• Japan: Japan’s market is expected to reach USD 28.5 million by 2034, representing 16.0% share with a CAGR of 3.46%, supported by educational research grants and mobile PET fleet expansion in national health programs.
• India: India is projected to record USD 24.6 million by 2034, maintaining 13.8% of global share and growing at a CAGR of 3.50%, boosted by research partnerships, affordable imaging solutions, and mobile diagnostic outreach initiatives.

Regional Outlook for the Pet Scanners Market

The PET Scanners Market Regional Outlook provides a detailed examination of geographic trends, quantifying the concentration of installed bases, scan utilization, and system adoption across the major regions — North America, Europe, Asia-Pacific, and the Middle East & Africa. Global PET system distribution remains highly uneven, with North America and Europe together accounting for approximately 70% of the total installed base, while Asia-Pacific and MEA collectively represent the remaining 30%.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

In North America the Pet Scanners Market Size and Share dynamic shows dominance by the region, estimated at roughly 41.7% of global share in 2025 per key industry sources. The U.S. leads with over 713.8 million USD market size in 2024 and hosts the bulk of PET/CT installations, while Canada and Mexico contribute significant incremental growth due to outpatient imaging centre expansion.

The North American PET Scanners Market is projected to reach USD 582.1 million by 2034, capturing approximately 39.6% of the global market share and expanding at a compound annual growth rate (CAGR) of 3.52% throughout the forecast period.

North America – Major Dominant Countries in the PET Scanners Market

• United States: The U.S. market is projected to reach USD 440.3 million by 2034, representing 75.6% of regional share and growing at a CAGR of 3.54%. The country’s leadership is driven by over 2,800 operational PET-CT systems, advanced R&D capabilities, and high annual PET scan volumes across major healthcare networks and research centers.
• Canada: Canada is forecasted to attain USD 66.9 million by 2034, accounting for 11.5% share and expanding at a CAGR of 3.48%. The country’s growth is supported by expanding diagnostic imaging programs, improved access to nuclear medicine technologies, and government initiatives to modernize hospital imaging facilities.
• Mexico: Mexico’s market is estimated to reach USD 42.6 million by 2034, representing 7.3% share and growing at a CAGR of 3.47%. Increased private investment in healthcare infrastructure, coupled with a growing number of outpatient diagnostic centers, continues to enhance PET imaging adoption rates.
• Cuba: Cuba is expected to reach USD 18.4 million by 2034, maintaining 3.1% of the regional share and registering a CAGR of 3.45%. Expansion of state-owned healthcare facilities and emphasis on early cancer detection are driving demand for cost-efficient PET imaging systems.
• Dominican Republic: The Dominican Republic is forecasted to achieve USD 13.9 million by 2034, representing 2.5% share with a CAGR of 3.44%. Growth is supported by the development of diagnostic imaging clinics and an increasing focus on preventive healthcare diagnostics.

EUROPE

In Europe the Pet Scanners Market Share is estimated at approximately 29% of global volume in 2025, driven by strong healthcare infrastructure, early adoption of PET/CT technologies and government support for oncology diagnostics. German, French, Italian and UK imaging centres account for the majority of European installations, with Germany alone estimated to contribute nearly 33% of European volume.

The European PET Scanners Market is anticipated to reach USD 418.9 million by 2034, accounting for 28.5% of global share and growing at a CAGR of 3.51%, reflecting the region’s established nuclear medicine infrastructure and widespread clinical acceptance of PET-CT imaging.

Europe – Major Dominant Countries in the PET Scanners Market

• Germany: Germany is projected to reach USD 137.4 million by 2034, representing 32.8% of the regional share and growing at a CAGR of 3.49%. Its dominance is supported by over 900 operational PET-CT scanners, advanced oncology imaging capabilities, and strong collaborations between hospitals and research institutions.
• United Kingdom: The United Kingdom is forecasted to reach USD 101.3 million by 2034, capturing 24.1% of Europe’s share and expanding at a CAGR of 3.47%. Growth is supported by rapid digital transformation in diagnostic imaging and expansion of hybrid imaging networks across NHS hospitals.
• France: France is estimated to record USD 84.5 million by 2034, holding 20.1% share and growing at a CAGR of 3.46%. The country’s healthcare infrastructure modernization and public–private imaging collaborations continue to drive PET-CT adoption across oncology and neurology departments.
• Italy: Italy’s market is expected to reach USD 58.1 million by 2034, representing 13.8% of Europe’s share and registering a CAGR of 3.45%. Strong government funding and radiopharmaceutical research advancements sustain Italy’s growth in hybrid PET imaging.
• Spain: Spain is forecasted to attain USD 37.6 million by 2034, accounting for 9.0% share and expanding at a CAGR of 3.44%. The rising prevalence of cancer and neurological disorders has increased PET scan utilization across major hospitals nationwide.

ASIA-PACIFIC

The Asia-Pacific region holds approximately 23% of global market share in 2025 for PET scanners, and reported injectable manufacturing and healthcare infrastructure expansion fueling diagnostic imaging growth. In 2023 PET scan volume growth in this region was about 18% year-on-year, reflecting increased adoption and capacity expansion in China, India and Southeast Asia. China is estimated to host around 14% of global PET installations, while India’s share of new imaging units rose by nearly 11% between 2022-2024.

The Asian PET Scanners Market is projected to reach USD 328.5 million by 2034, capturing 22.4% of the global market share and expanding at a CAGR of 3.53%.

Asia – Major Dominant Countries in the PET Scanners Market

• China: China’s market is forecasted to reach USD 132.1 million by 2034, representing 40.2% share with a CAGR of 3.54%. Expanding healthcare reforms, growing PET installation bases, and localized tracer production continue to drive rapid imaging adoption in tertiary hospitals.
• Japan: Japan is projected to achieve USD 89.5 million by 2034, capturing 27.2% of regional share and growing at a CAGR of 3.49%. The country’s innovation-driven healthcare system and increasing investments in oncology research underpin its stable PET scanner utilization.
• India: India’s market is estimated to reach USD 68.7 million by 2034, representing 20.9% of Asia’s share and expanding at a CAGR of 3.51%. The surge in diagnostic center networks, rising patient awareness, and government support for nuclear medicine drive market expansion.
• South Korea: South Korea is expected to record USD 25.6 million by 2034, holding 7.8% share and growing at a CAGR of 3.46%. High adoption of hybrid PET-CT scanners in hospitals and continuous oncology screening initiatives are fueling market demand.
• Thailand: Thailand is projected to reach USD 12.6 million by 2034, maintaining 3.9% share and expanding at a CAGR of 3.44%. Increasing investment in healthcare modernization and medical tourism are key growth contributors in the region.

MIDDLE EAST & AFRICA

In Middle East & Africa the Pet Scanners Market Share is estimated at about 10% of global share in 2025, supported by healthcare modernisation initiatives in Gulf Cooperation Council (GCC) countries and rising vaccine/oncology diagnostic demand. In 2023 the region’s imaging centre expansion contributed to a 12% year-on-year increase in PET/CT installations and about 15% growth in radiopharmaceutical supply certified sites.

The Middle East and Africa PET Scanners Market is forecasted to reach USD 138.7 million by 2034, accounting for 9.5% of global market share and registering a CAGR of 3.48%. Regional growth is driven by rising investments in healthcare infrastructure, expansion of diagnostic imaging facilities, and government-backed programs promoting nuclear medicine education and adoption.

Middle East and Africa – Major Dominant Countries in the PET Scanners Market

• United Arab Emirates: The UAE market is projected to reach USD 38.5 million by 2034, capturing 27.8% of regional share and growing at a CAGR of 3.49%. The country’s healthcare innovation strategy and expanding diagnostic center network have accelerated PET imaging adoption.
• Saudi Arabia: Saudi Arabia is expected to reach USD 34.2 million by 2034, accounting for 24.6% share with a CAGR of 3.47%. Government healthcare diversification plans and cancer-screening investments continue to strengthen PET installation growth.
• South Africa: South Africa is forecasted to achieve USD 30.6 million by 2034, representing 22.1% share and growing at a CAGR of 3.46%. Expanding private diagnostic centers and partnerships with radiology service providers fuel consistent market growth.
• Egypt: Egypt is estimated to reach USD 23.7 million by 2034, capturing 17.0% share with a CAGR of 3.45%. Increasing PET imaging installations in Cairo and Alexandria hospitals support the country’s growing medical imaging capabilities.
• Israel: Israel is projected to record USD 11.7 million by 2034, representing 8.5% share and growing at a CAGR of 3.44%. Its leadership in medical technology innovation and robust research institutions enhance PET imaging adoption rates regionally.

List of Top Pet Scanners Companies

• Neurologica Corp.
• Toshiba
• Hitachi Medical
• GE
• Rigaku
• Philips
• Picker
• Siemens
• Bruker
• MedRad

Siemens: Captures approximately 18% of global PET and PET/CT equipment shipments in 2023 and holds the largest share among OEMs due to broad product range and service network.

GE: Holds roughly 16% of the global Pet Scanners Market share in 2023, supported by hybrid PET/CT platforms, strong installed base and aftermarket service offerings globally.

Investment Analysis and Opportunities

Investment analysis in the Pet Scanners Market indicates strong capital commitment toward equipment installation, service contracts and radiopharmaceutical infrastructure. In 2023 imaging centres globally invested in more than 8,000 new PET/CT units and the average purchase order value increased by approximately 9% year-on-year, reflecting advanced feature inclusion.

New Product Development

New product development in the Pet Scanners Market Research Report highlights enhancements in imaging speed, sensitivity and workflow integration. For example, a leading OEM introduced a PET/CT scanner in 2023 with a time-of-flight (TOF) detector achieving 178 picoseconds resolution and enabling scan times under 20 minutes, while average per-site throughput increased by about 8%. In 2024, digital PET detector platforms were deployed in around 34% of new installations, delivering improved spatial resolution and lower dose requirements.

Five Recent Developments

• In 2023 a major PET/CT OEM commissioned a production ramp of 500 units of its new full-ring digital detector platform, representing a 25% capacity increase.
• In 2023 a mobile PET unit leasing company secured 150 contracts across North America, with average site utilization rising from 1,300 scans per annum to 1,450.
• In 2024 a leading imaging services provider added 220 outpatient diagnostic centres equipped with PET/CT scanners, marking a 11% expansion in network size.
• In 2024 a radiopharmaceutical manufacturer expanded production of F-18 FDG tracer by 18%, enabling increased PET scan volumes at over 270 sites globally.
• In early 2025 an equipment OEM launched a hybrid PET/CT/MRI scanner with multi-modality capability at 31% lower weight than previous models and secured orders for 75 units by Q2.

Report Coverage of Pet Scanners Market

The Pet Scanners Market Report provides a comprehensive assessment of equipment demand, installation volumes, regional deployment and competitive dynamics across the PET and PET-CT imaging segments. The report spans historical data from 2018-2023, includes unit shipment figures (more than 1,495 average scans per fixed site in 2023), and projects expansion through 2030-2035. Segmentation covers product types (PET only vs PET-CT), end-use applications (hospitals, diagnostic centres, pharmaceutical companies, other) and geographic regions (North America, Europe, Asia-Pacific, Middle East & Africa).

Pet Scanners Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 1114.5 Million in 2026
Market Size Value By	USD 1519.74 Million by 2035
Growth Rate	CAGR of 3.51% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : PET Scanners (Only Including PET) PET-CT Scanners By Application : Hospitals/ Clinics Pharmaceutical Companies Diagnostic Center Other
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample